Skip to main content
Premium Trial:

Request an Annual Quote

Einstein College of Medicine Lands $9.5M for Diabetes Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has given the Albert Einstein College of Medicine of Yeshiva University nearly $10.2 million through two new grants to fund its Diabetes Research and Training Center (DRTC), which conducts genetics and molecular research, among other disciplines.

The DRTC has six cores, including ones focused on epigenomics, metabolomics, flow cytometry, animal physiology, analytical imaging, and hormone assay research.

In addition to the five-year, $9.5 million grant from the National Institute of Digestive and Kidney Diseases, the new funding includes a $632,000 supplemental grant for equipment and pilot and feasibility studies awarded through the American Recovery and Reinvestment Act.

"The ultimate goal of these studies is to develop new therapies for the prevention or treatment of diabetes," Jeffrey Pessin, director of the DRTC and a professor of medicine and of molecular pharmacology at Einstein, said in a statement.

Some of the DRTC's research efforts are conducted at the Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion, a 223,000-square-feet facility that was completed in 2008 at Yeshiva's campus in Bronx, NY.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.